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Purpose: To assess the estimate prevalence and risk factors
for age-related maculopathy (ARM) in Seoul, Korea. Patients
and Methods: We examined 9,530 subjects with, 40 years of
age or older between January 2006 and December 2006 in
Seoul, Korea. Subjects underwent fundus photography, clinical
examinations (including blood analyses), and completed
detailed questionnaires. Fundus images were graded according
to definitions from the Wisconsin Age-Related Maculopathy
Grading System. Results: ARM was present in 235 subjects,
corresponding to an estimate prevalence of 2.46%. Hepatitis
B infection (positive status for HBsAg and HBcAb), serum
triglyceride levels and high density lipoprotein levels remained
as significant risk factors after age-adjustment. Multivariate
analyses showed that the prevalence of ARM was significantly
higher in older subjects [odds ratio (OR) 1.134; 95% CI 1.114-
1.154] and those who were seropositive for hepatitis B surface
antigen (OR 2.566; 95% CI 1.519-4.335). Conclusion: The
estimated prevalence of ARM was 2.46%. Age and hepatitis
B infection may increase the risk of ARM.
Key Word: Age-related maculopathy, hepatitis B, triglyceride,
high-density lipoprotein
INTRODUCTION
Age-related maculopathy (ARM) is the main
cause of adult blindness in developed countries.
1
Although there is considerable information on the
nature and prevalence of visual impairment and
blindness in Western countries, only a few popula-
tion-based articles have appeared, describing the
prevalence of ARM and the association of ARM
with various patient characteristics in different
racial and ethnic groups in Western countries.
2-5
Only limited population-based data on the pre-
valence, characteristics, and risk factors for ARM
in Asian populations are available.
6-13
Studies from Western countries implicate lifestyle
choices, nutritional parameters, and genetic risk
factors in the pathogenesis of ARM.
14 Known risk
factors for developing ARM are age,
14-18 smoking,
14-17,19-21 and hypertension.
22-24 Hyperlipidemia and
fat intake are related to the presence of exudative
ARM,
24 and obesity
25-28 and atherosclerosis
24 con-
tribute to ARM development in some studies.
Asian lifestyles and nutritional choices are differ-
ent, however, from those of Western populations.
The purpose of this report is to provide an estimate
of the prevalence of ARM in a large survey sample,
and to evaluate possible risk factors for ARM in
the South Korean population.
PATIENTS AND METHODS
The Yonsei Eye Study was carried out in Seoul,
which is the largest city in South Korea. The
Medical Ethics Committee of the Yonsei Uni-
versity medical center approved the study protocol,
and all participants were well-briefed on the pur-
poses of the study before giving written informed
consent in accordance with the tenets of the
Declaration of Helsinki. Baseline interviews and
ophthalmic examinations, with concurrent general
medical examinations, took place between January
2006 and December 2006. Of 13,016 participants
who came in for a health check-up during that
period, 9,530 subjects (73.2%) were 40 years old.
All examinations were carried out at the Yonsei
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Medical Examination Center in Seoul, Korea. After
measuring visual acuities and intraocular pressures
(using a Type WT-200 instrument; Canon Inc,
Tokyo, Japan), digital photographs of the maculae
and optic discs were taken using a digital fundus
camera (model TRC.NW 100; Topcon, Tokyo,
Japan). Medical examinations were performed,
which included blood analyses, urine analyses,
and electrocardiograms. Additionally, the educa-
tion level, income status, smoking habits, and
illness history of each subject were assessed by
questionnaire. Subjects were asked to report exist-
ing or previous diagnoses of diabetes mellitus,
hypertension, cardiac disease, or hepatic disease.
Ophthalmic examination
For the assessment of ARM, the Wisconsin Age-
Related Maculopathy Grading system was used, as
described previously in detail.
29,30 Fundus photo-
graphs were examined by ophthalmologists with
special training in retinal diseases (MIR, JHK).
Intergrader and intragrader agreement was assess-
ed using the quadratic weighted kappa statistic on
a random subset of 30 subjects. There was excellent
inter-and intraobserver agreement (κ = 0.82) for the
grading of fundus photographs. Senior investiga-
tors also reviewed all photographs graded as late
ARM (ARM 4). Grading of the fundus photographs
was based on the staging systems developed by
the investigators of the Rotterdam Eye Study
31:
ARM 0, no feature characteristic of early ARM, or
hard drusen only; ARM 1, either soft drusen or
pigmentary irregularities only; ARM 2, either soft,
indistinct ( 125 m) or reticular drusen only, or μ
soft, distinct, drusen with pigmentary irregul-
arities; ARM 3, soft, indistinct, or reticular drusen
with pigmentary irregularities; and ARM 4, neo-
vascular ARM or geographic atrophy. Neovascular
ARM was considered to be present if any of the
following lesions were found: serous or hemor-
rhagic retinal pigment epithelial detachment,
subretinal neovascular membrane, or subretinal
hemorrhage. Geographic atrophy was considered
to be present if preretinal fibrous scarring or retinal
pigment atrophy with visible choroidal vessels was
found. We defined ARM stage 2 and 3 as early
ARM and stage 4 as late ARM. Subjects were ex-
cluded from the study whose fundi could not be
graded because of poor photograph quality or
dense ocular media.
Data analysis
For smoking analysis, subjects were categorized
as non-smokers (those who had never smoked),
current smokers, and prior smokers (those who
had smoked earlier but were not smoking for 6
months at the time of the study). Education level
was graded on the basis of final education level
attained, as follows: 0, no school education; 1,
graduated from elementary school; 2, graduated
from middle school; 3, graduated from high school;
4, bachelors degree from college and, 5; masters
degree from college. Monthly income was divided
into 6 categories: 1, monthly income less than 1.5
million won; 2, monthly income between 1.5
million and 2.5 million won; 3, monthly income
between 2.5 million and 3.5 million won; 4, month-
ly income between 3.5 million and 4.5 million won;
5, monthly income between 5.5 million won and
6.5 million won, and; 6, monthly income more than
6.5 million won. Hypertension and hepatitis were
considered to be present when subjects self-
reported these conditions, and diabetes was con-
sidered to be present when subjects self-reported
the condition and the self-report was confirmed by
a measurement of fasting blood glucose level > 126
mg/dL.
Statistical analyses
Student t-test was used for analyses of con-
tinuous variables, and the Pearson 
2 test was also
employed for nominal variables. Age-adjusted
logistic regression analysis was performed to
determine risk factors for early and late ARM,
using odds ratio calculations, and estimations of
the 95% confidence intervals. We then developed
multivariable models using the following pro-
cedure. The initial specification included indepen-
dent variables consistently identified in previous
research as risk factors for early and late ARM, or
independent variables identified in univariate
analyses as related to outcomes (p > 0.10). We then
sequentially removed non-significant (p > 0.15)
covariates, making it certain that these eliminations
did not change estimated coefficients of the ex-Estimated Prevalence and Risk Factor for Age-related Maculopathy
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posure variable by more than 10%.
32 Age and
gender were adjusted regardless of association.
Because our models might have been overspeci-
fied, given the limited number of ARM in the study
group, we also constructed reduced form models
by selecting covariates, based on their statistical
significance in the adjusted models. SPSS version
12 (SPSS Inc, Chicago, IL, USA) was used to per-
form statistical analyses. A two sided p value <
0.05 was considered to be statistically significant.
RESULTS
Study population
A total of 13,016 potential participants (7,109
men and 5,770 women), who underwent examina-
tions at the Yonsei Medical Examination Center
between January 1, 2006 and December 31, 2006,
were identified. Of the participants, 9,530 (73.2%)
were aged 40 years, and underwent full clinical
examinations. Of these, 9,468 (99.3%) completed all
study procedures, including dilated fundus photo-
graphy. Fundus images were not available for 62
(0.7%) participants because subjects refused to be
photographed, and poor-quality, unusable photo-
graphs were obtained from 151 (1.6%) subjects
because of corneal opacities, phthisis bulbi, or
small pupils. Table 1 shows the prevalence of ARM
by gender and age. Percentages of the population
in various age groups were 42.3% in the group
aged 40 - 49 years, 36.0% in the group aged 50 - 59
years, 17.3% in the group aged 60 - 69 years, and
4.5% in the group aged 70 years. ARM was seen
in 235 (2.46%) subjects. Estimated prevalence of
early ARM (ARM 2 and ARM 3) and late ARM
(ARM 4) increased from 0% and 0.1%, respectively,
in the 40 - 49 year age group, to 2.0% and 0.1% in
the group aged 50 - 59 years, to 6.7% and 0.2% in
the group aged 60 - 69 years, and to 8.0% and 2.4%
in subjects aged 70 years.
Mean age of the subjects with ARM was 63.17
± 7.45 years[mean ± standard deviation (SD)]. One
hundred and twenty-six (53.6%) ARM patients
were male and 109 (46.4%) were female, thus males
showing a slight predominance. Early ARM and
late ARM were present in 2.3% (215 subjects) and
Table 1. Numbers of Subjects over 40 Years of Age with ARM, and ARM Prevalence Rates (%)
No pathology ARM 1 ARM 2 ARM 3 ARM 4 Ungradable photograph No photo
All ages
Men
(n = 5,425)
5,166
95.2%
13
0.2%
101
1.9%
14
0.3%
11
0.2%
82
1.5%
38
0.7%
Women
(n = 4,105)
3,884
94.6%
19
0.5%
88
2.1%
12
0.3%
9
0.2%
69
1.7%
24
0.6%
Total
(n = 9,530)
9,050
95.0%
32
0.3%
189
2.0%
26
0.3%
20
0.2%
151
1.6%
62
0.7%
Age group (yrs)
40 - 49
(n = 4,026)
3,982
98.9%
2
0%
2
0%
1
0%
4
0.1%
14
0.3%
21
0.5%
50 - 59
(n = 3,429)
3,286
95.8%
18
0.5%
61
1.8%
7
0.2%
2
0.1%
37
1.1%
18
0.5%
60 - 69
(n = 1,651)
1,443
87.4%
12
0.7%
100
6.1%
10
0.6%
4
0.2%
69
4.2%
13
0.8%
70
(n = 424)
339
80.0%
0
0.0%
26
6.1%
8
1.9%
10
2.4%
31
7.3%
10
2.4%
ARM, age-related maculopathy.
0, no features of early ARM, or hard drusen only; 1, either soft drusen or pigmentary irregularities only; 2, either soft, indistinct
( 125 m), or reticular drusen only, or soft, distinct, drusen with pigmentary irregularities; 3, soft, indistinct, or reticular drusen, μ
with pigmentary irregularities; 4, neovascular ARM or geographic atrophy.Mi In Roh, et al.
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0.2% (20 subjects) of participants, respectively.
Among these, ARM was bilateral in 123 subjects
(52.3%) and unilateral in 112 subjects (47.7%).
Among bilateral subjects, geographic atrophy was
found in both eyes in a single subject, and 2
subjects each showed geographic atrophy in 1 eye
and multiple drusens in the other eye. The remain-
ing subjects showed multiple drusens in both eyes
with or without pigment abnormalities. Among
the unilateral ARM subjects, 17 (15.2%) eyes
showed late ARM (neovascular AMD in 5 subjects
and geographic atrophy in 12 subjects), and
remaining 95 eyes showed early ARM. Among
ARM subjects, there were no differences in dis-
tributions of ARM features between males and
females (ARM 2, ARM 3, and ARM 4) (Pearson
chi-square test, p = 0.991), or late ARM features
(Pearson chi-square test, p = 0.897). Bilateral ARM
was more prevalent in females (Pearson chi-square
test, p = 0.011).
Neovascular AMD was found in 5 subjects.
Among these, 2 patients showed subretinal hemor-
rhages with exudates, a single subject showed
serous pigment epithelial detachment with hyper-
pigmentation, and 2 subjects had large subretinal
hemorrhages with orange nodules.
Risk factors for ARM
When Student t-test and Pearson 
2 test were
used for analyses of variables, the following risk
factors for early and late ARM (ARM 2, 3 and 4)
were subjected to age-adjusted univariate analysis:
gender, socioeconomic status (monthly income and
education level), smoking history, self-reported
diagnosis of hypertension, self-reported diagnosis
of cerebral vascular accident, self-reported diagno-
sis of hepatitis, and body mass index. Serum levels
of cholesterol, triglycerides (TG), high-density
lipoprotein (HDL), low-density lipoprotein (LDL),
lactate dehydrogenase (LDH) and C-reactive
protein (CRP) were measured. In addition, serum
hepatitis B surface antigen status (HBsAg), hepa-
titis B core antibody level (HBcAb), hepatitis B
surface antibody level (HBsAb), and hepatitis C
antibody level (HCVAb) were also assessed.
Subjects with ARM were significantly older (p
< 0.001), and monthly income and final education
level were lower than subjects without ARM. Also,
while 27% of the ARM subjects had hypertension,
only 14.1% of the subjects without ARM had hyper-
tension history (p < 0.001). As for blood sample
analysis, significantly different platelet, LDH, and
TG levels were found with ARM subjects (Table 2).
Therefore, estimated prevalence of ARM was
strongly age-related (logistic regression; p < 0.001;
OR 1.134; 95% CI; 1.114 - 1.154), as expected. The
results of age-adjusted logistic regression analyses
of risk factors for ARM are listed in Table 3. After
adjusting for age, hepatitis B infection (positive
status for HBsAg and HBcAb) and serum trigly-
ceride levels and HDL levels remained as signi-
ficant risk factors for ARM. Multivariate regres-
sion analysis indicated that serum HBsAg-posi-
tive status was significant and associated with a
> 2-fold increase in the risk of ARM, relative to
normal macular subjects, in both the adjusted (OR
2.55 ; 95% CI 1.476 - 4.421) and reduced (OR 2.736;
95% CI 1.588 - 4.714) analyses (Table 4).
DISCUSSION
We estimated the prevalence and risk factors for
ARM in Seoul, Korea. In our study population,
2.46% of participants had signs of early or late
ARM in one or both eyes, suggesting that ARM
is relatively rare among adult South Koreans in
Seoul. A total of 2.26% of the study subjects
showed early ARM, defined as soft indistinct
drusen with or without pigmentation abnor-
malities. Late ARM (defined as neovascular AMD
or geographic atrophy) was seen in 0.2% of the
study population. Among those with late ARM,
neovascular AMD in at least one eye was seen in
5 subjects and geographic atrophy in 15 subjects.
Although direct comparison is difficult due to
the fact that our studies showed estimate pre-
valence of ARM, these estimates of early and late
ARM are lower than the incidence rates observed
in Western countries. In the Beaver Dam study,
33
the prevalence of indistinct soft drusen was 8.4%
and patients with either pure geographic atrophy
or exudative macular degeneration constituted
0.6% of the study population. The Framingham
Eye Study
34 showed an incidence of 1.5% of exuda-
tive macular degeneration in people 52 years of
age. In a population-based prevalence study (theEstimated Prevalence and Risk Factor for Age-related Maculopathy
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Table 2. Statistical Data on Risk Factors for Age-related Maculopathy
Variables ARM No-ARM p value
Age, yrs (mean ± SD) 63.17 ± 7.45 52.14 ± 8.51 < 0.001
Gender, male/total (%) 126/235 (53.6) 5,205/9,126 (57) 0.296
Body mass index (kg/m
2) 24.26 ± 2.91 24.27 ± 2.81 0.986
Socioeconomic status
Monthly income/month (million won)
< 1.5 0/207 (0) 1/8,218 (0.0) < 0.001
1.5 - 2.5 42/207 (20.3) 730/8,218 (8.9)
2.5 - 3.5 40/207 (19.3) 951/8,218 (11.6)
3.5 - 4.5 36/207 (17.4) 1,079/8,218 (13.1)
4.5 - 5.5 16/207 (7.7) 1,213/8,218 (14.8)
> 5.5 73/207 (35.3) 4,244/8,218 (51.6)
Education level
No school education 0/225 (0) 2/8,846 (0.0) < 0.001
Graduated from elementary school 40/225 (17.8) 627/8,846 (7.1)
Graduated from middle school 26/225 (11.6) 687/8,846 (7.8)
Graduated from high school 62/225 (27.6) 2,299/8,846 (26)
More than college education 97/225 (43.1) 5,231/8,846 (59.1)
Cerebral vascular accident (%) 4/235 (1.7) 79/9,126 (0.9) 0.177
Hypertension (%) 65/235 (27.7) 1,285/9,126 (14.1) < 0.001
Diabetes mellitus (%) 38/235 (16.2) 1,654/9,126 (18.1) 0.442
Hepatitis (%) 13/235 (5.5) 459/9,126 (5.0) 0.728
Current Smoking (%) 32/223 (14.3) 1,815/8,836 (20.5) 0.066
Blood sampling
Hemoglobin (g/dL) 14.13 ± 1.31 14.25 ± 1.49 0.212
Platelets (k/µL) 240.89 ± 57.88 251.16 ± 56.43 0.006
White blood cell count (k/µL) 6.10 ± 1.67 5.94 ± 1.70 0.129
Cholesterol (mg/dL) 188.36 ± 31.67 188.24 ± 32.22 0.953
Triglycerides (mg/dL) 131.39 ± 66.83 142.51 ± 92.45 0.013
HDL (mg/dL) 56.64 ± 12.24 56.39 ± 13.04 0.755
LDL (mg/dL) 127.29 ± 29.80 126.51 ± 31.13 0.701
LDH (IU/L) 360.51 ± 58.40 341.03 ± 56.42 < 0.001
CRP quantitation (mg/dL) 0.19 ± 0.37 0.18 ± 0.39 0.785
HBsAg positivity 18/235 (7.7) 410/9,126 (4.5) 0.022
HBsAb positivity 155/235 (66) 6,518/9,126 (71.4) 0.068
HBcAb positivity 175/235 (73.2) 5,170/9,126 (56.7) < 0.001
HCVAb positivity 1/235 (0.4) 78/9,126 (0.9) 0.478
ARM, age related maculopathy = ARM2 + ARM3 + ARM4; SD, standard deviation; HDL, high-density lipoprotein; LDL, low-
density lipoprotein; LDH, lactate dehydrogenase; CRP, C-reactive protein; HBsAg, hepatitis B surface antigen; HBsAb, hepatitis
B surface antibody; HBcAb, hepatitis B core antibody; HCVAb, hepatitis C antibody.
Chi-square test was used for nominal variables.
Student's t test was used for continuous variables.Mi In Roh, et al.
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Beijing Eye Study), Li et al.
13 found that the overall
prevalence rates of early and late ARM were 1.4%
and 0.2%, respectively, and these data are similar
to our results. The prevalence of late ARM in the
black population was 0.59% in a Barbados study,
4
and was 0.5% in Hispanic individuals aged 50
years in Arizona.
35
The prevalence of early ARM obtained in the
present study on South Koreans living in the Seoul
area was slightly higher (2.46% vs. 1.4%) than in
Table 3. Age-adjusted Univariate Logistic Analyses to Find Associations of Prevalence Rates of ARM with Other
Parameters
Variables
ARM
Age-adjusted
p value OR (95% CI)
Sex 0.396 1.123 (0.859 - 1.468)
Body mass index (kg/m
2) 0.779 0.993 (0.947 - 1.042)
Socioeconomic status
Monthly income/month 0.910 0.995 (0.917 - 1.081)
Education level 0.582 0.970 (0.868 - 1.083)
Self-reported diagnosis
Cerebral vascular accident 0.277 1.803 (0.622 - 5.220)
Hypertension 0.437 1.131 (0.829 - 1.542)
Diabetes mellitus 0.978 1.005 (0.699 - 1.445)
Hepatitis 0.162 2.514 (0.691 - 9.148)
Current Smoking 0.866 1.034 (0.700 - 1.528)
Blood sampling
Hemoglobin (g/dL) 0.709 1.019 (0.924 - 1.123)
Platelets (k/µL) 0.261 0.999 (0.996 - 1.001)
White blood cell count (k/µL) 0.678 1.013 (0.952 - 1.078)
Cholesterol (mg/dL) 0.459 0.998 (0.994 - 1.003)
Triglycerides (mg/dL) 0.017 0.998 (0.996 - 1.000)
HDL (mg/dL) 0.040 1.011 (1.000 - 1.021)
LDL (mg/dL) 0.570 0.999 (0.995 - 1.003)
LDH (IU/L) 0.820 1.000 (0.998 - 1.003)
CRP quantitation (mg/dL) 0.303 0.813 (0.548 - 1.205)
HBsAg positivity < 0.001 2.653 (1.591 - 4.425)
HBsAb positivity 0.547 0.916 (0.690 - 1.218)
HBcAb positivity 0.011 1.475 (1.092 - 1.992)
HCVAb positivity 0.103 0.187 (0.025 - 1.405)
ARM, age related maculopathy = ARM2 + ARM3 + ARM4; HDL, high-density lipoprotein; LDL, low-density lipoprotein; LDH,
lactate dehydrogenase; CRP, C-reactive protein; HBsAg, hepatitis B surface antigen; HBsAb, hepatitis B surface antibody; HBcAb,
hepatitis B core antibody; HCVAb, hepatitis C antibody; OR, odds ratio; 95% CI, 95% confidence interval.Estimated Prevalence and Risk Factor for Age-related Maculopathy
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the Chinese population group of the Beijing Eye
Study,
13 nevertheless, the two studies yielded
similar estimates of the prevalence of late ARM
(0.2% vs. 0.2%). The prevalence rates of early ARM
in the age groups of 40 - 49 years, 50 - 59 years, 60
- 69 years, and 70 years were 1.54%, 2.74%,
3.41%, and 6.31%, respectively, in the Beijing study.
In the same study, prevalence rates of late ARM
were 0.14%, 0.52%, 0.14% and 1.11%, respectively,
in these age groups. These figures are similar to our
data (Table 1). The slight between-study difference
in prevalence of early ARM might have been due
to a population difference, geographic difference
(rural vs. urban), ethnic differences between Chinese
and Koreans, differences in dietary or nutritional
habits, environmental parameters, and difference
in the study design.
Several studies
14-19,22,23 have identified risk factors
for ARM, and both population-based studies and
case control studies have been carried out. Re-
fractive error,
36-38 iris color,
39,40 hypertension and
cardiovascular disease,
23,24,28,41 smoking,
20,41-44 and
alcohol consumption,
44-46 are known risk factors for
ARM. In our study, age was significantly associ-
ated with estimated early and late ARM pre-
valence, as expected. When adjustments were
made for subject age in univariate analysis,
seropositivity for HBsAg and HBcAb, indicating
(past or present) infections with hepatitis B, serum
levels of HDL and TG all remained significantly
associated with ARM (Table 3).
Two previous studies
47,48 have demonstrated
statistically insignificant, but inverse associations
between education levels attained and ARM.
Although crude analysis showed significant rela-
tionships between education level and monthly
income and ARM (Table 2), no significant inverse
association was noted after age adjustment (p =
0.582, OR 0.970, 95% CI 0.868 - 1.083 for education,
p= 0.910, OR 0.995, 95% CI 0.917- 1.081 for monthly
income).
Also, although smoking has been reported to be
Table 4. Multivariate Logistic Analysis of Risk Factors for ARM
Variables
ARM
Unadjusted model
OR (95% CI)
Adjusted model*
OR (95% CI)
Reduced form model
OR (95% CI)
Primary independent variable
HBsAg positivity 1.763 (1.079 - 2.881) 2.555 (1.476 - 4.421) 2.736 (1.588 - 4.714)
Adjustment variable
Age (yrs) - 1.135 (1.115 - 1.156) 1.134 (1.114 - 1.154)
Sex - 1.019 (0.716 - 1.449) 1.090 (0.772 - 1.538)
Monthly income/month - 1.020 (0.925 - 1.125) 1.023 (0.928 - 1.128)
Education level - 0.929 (0.800 - 1.078) 0.942 (0.812 - 1.092)
Body mass index (kg/m
2) - 0.997 (0.942 - 1.055)
Hypertension - 1.305 (0.920 - 1.852) 1.239 (0.880 - 1.745)
Current smoking - 1.172 (0.752 - 1.827) 1.104 (0.712 - 1.713)
CRP quantitation (mg/dL) - 0.579 (0.302 - 1.113) -
Triglycerides (mg/dL) - 0.998 (0.996 - 1.001) -
HDL (mg/dL) - 1.005 (0.991 - 1.018) -
ARM, age related maculopathy = ARM2 + ARM3 + ARM4; BMI, body mass index; HDL, high-density lipoprotein; CRP, C-reactive
protein; OR, odds ratio; 95% CI, 95% confidence interval.
*Hosmer and Lemeshow Test: p = 0.239.
Hosmer and Lemeshow Test: p = 0.260.Mi In Roh, et al.
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one of risk factors for ARM, our study showed no
definite association between smoking and ARM (p
= 0.866, OR 1.034, 95% CI 0.700 - 1.528). This might
have been due to relatively small number of late
ARM in our study, which is more likely related
with smoking.
20,42
One of the most distinct risk factors for ARM
found in the present study is the association
between hepatitis B and ARM in South Korea.
Even after adjusted multivariate analysis for
socioeconomic factors such as education level and
monthly income in this study, HBsAg (p < 0.001;
OR 2.736; 95% CI 1.588 - 4.714) and anti HBc
antibody (p < 0.05; OR 1.475; 95% CI 1.092 - 1.992)
were significantly associated with ARM, (Tables 3
and 4). The statistical significance of both HBs
antigen and anti HBc antibody with ARM suggest
that there is less opportunity than that this asso-
ciation is by chance alone (1/20 × 1/20 = 1/400).
The reason why there has been no epidemiologic
study about Hepatitis B and ARM was that Hepa-
titis viral marker has not been included as covaria-
tes in previous epidemiologic studies. Since Hepa-
titis B infection is highly prevalent in South Korea,
viral markers were checked in most examinees.
Although the prevalence of hepatitis B surface
antigenemia has declined because of an effective
vaccination program, HBV remains endemic in
South Korea. Seropositivity for HBsAg was esti-
mated at 7 - 9% in the 1980s.
49 It was also reported
in 1998 Korean National Health and Nutrition
survey that prevalence of HBsAg was 5.1% in
males and 4.1% in females, with low prevalence
rates in individuals under 20 years old.
50 There is
a biologic plausibility underlying this association.
First, HBs Ag is found in subretinal fluids with
increased detection rate of antibodies to S-antigen
in healthy virus carriers, increasing risk for uveore-
tinal pathology.
51,52 This inflammatory process may
induce drusen formation. Secondly, molecular
mimicry between retinal S-antigen and Hepatits S
antigen
53,54 can induce cross reactivity which can
predispose to uveoretinal inflammation. Further-
more, as viral hepatitis is associated with de-
creased level of complement C3, C4 and comple-
ment factor H related protein 1,
55 this may activate
the alternative complement pathway, thereby
increasing the risk of drusen formation.
56
Associations between ARM and hypertension,
cardiovascular disease,
23,24,28 serum lipid level,
14,41
obesity,
24,27 cardiovascular biomarkers,
28,57-59 and
BMI
26 have previously been documented. In our
subjects, no significant associations between ARM
and hypertension, serum cholesterol level, or
cardiovascular biomarker CRP were found after
age-adjustment. The serum level of TG was inve-
rsely associated with the prevalence of ARM,
whereas the serum level of HDL showed a signifi-
cant positive association. However, the association
between low TG level, high HDL level and ARM
adjusted for age was not maintained in the adjusted
model (Table 4), which was adjusted for age, HBs
Ab positivity, gender and hypertension. This could
be explained by the positive confounding by one
or more of the above risk factors for ARM, although
there are some reports to support the association
between low TG, high HLD and ARM.
28,57-59
Strength of this study is the relatively large
number of subjects examined. The protocol was
standardized, thereby providing an accurate
estimate of the prevalence, and risk factors for
ARM in Seoul, Korea. Also, the strength of this
study is that socioeconomic factors, cardiovascular
risk factors, and hepatitis viral markers were
considered for analysis. A limiting factor of the
present study is that this is a cross-sectional design
which cannot assess the causality. Therefore, pro-
spective data are needed to confirm the issue of
ARM causality. Although this data may not repre-
sent the general population of South Korea, sub-
jects were those who visited the health examina-
tion center for regular check-ups, but not for the
treatment of confirmed disease, which may lower
the selection bias compared with previous hos-
pital-based studies. Moreover, since there was
only small number of subjects with ARM, the
power of the study to identify all significant
factors may be decreased. Therefore, the results of
the present study may be taken as practical evidence
for those associations that were statistically signi-
ficant, but not as a proof for those associations
which did not show statistical significance. Also,
subjects, in whom a dense cataract or hazy cornea
media were considered to be reasons for visual
impairment, might additionally have had ARM.
This fact might artificially reduce the prevalence
figures for ARM.
In conclusion, the single most important riskEstimated Prevalence and Risk Factor for Age-related Maculopathy
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factor for ARM in our study, besides age, is
seropositivity for HBsAg. However, factors such as
current smoking, history of previous smoking, and
the level of smoking, in addition to self-reported
diagnoses of systemic diseases such as diabetes
mellitus and cerebrovascular condition which had
previously been reported as risk factors for ARM,
did not show statistically significant influences on
the prevalence of ARM in this study.
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